Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Dow
Deloitte
Healthtrust
Covington
Baxter
Johnson and Johnson
Novartis
Teva
Fish and Richardson

Generated: October 19, 2017

DrugPatentWatch Database Preview

Hikma Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has one hundred and fifty-six approved drugs.

There are four US patents protecting HIKMA drugs. There are two tentative approvals on HIKMA drugs.

Summary for Applicant: Hikma

US Patents:4
Tradenames:117
Ingredients:110
NDAs:156
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
acetaminophen; butalbital; caffeine
TABLET;ORAL089718-001Jun 12, 1995AARXNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
MEFLOQUINE HYDROCHLORIDE
mefloquine hydrochloride
TABLET;ORAL077699-001Apr 21, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma
CEFOTAXIME
cefotaxime sodium
INJECTABLE;INJECTION065071-001Nov 20, 2002APRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
ZALEPLON
zaleplon
CAPSULE;ORAL078147-001Nov 25, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma
GLYBURIDE (MICRONIZED)
glyburide
TABLET;ORAL075890-002Jul 31, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL065191-002Jan 25, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma
CIPROFLOXACIN HYDROCHLORIDE
ciprofloxacin hydrochloride
TABLET;ORAL076558-004Jun 9, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL090247-002May 31, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
PREDNISONE
prednisone
TABLET;ORAL040890-001Nov 1, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
acetaminophen; butalbital; caffeine
TABLET;ORAL040336-001Aug 18, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for HIKMA drugs

Drugname Dosage Strength Tradename Submissiondate
argatroban in sodium chloride
Injection1 mg/mL, 50 mL vials
ARGATROBAN
12/16/2011
argatroban
Injection100 mg/mL, 2.5 mL vials
ARGATROBAN
9/24/2007

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Julphar
Dow
QuintilesIMS
Novartis
Accenture
US Department of Justice
Deloitte
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot